AHRQ poses questions on VTE prophylaxis
This article was originally published in The Gray Sheet
Executive Summary
Agency for Healthcare Research and Quality is taking comments through June 4 on the comparative effectiveness of venous thromboembolism (VTE) prophylaxis in orthopedic surgery. Key questions posted online May 7 address the overall baseline risk of VTE and bleeding outcomes in patients undergoing major orthopedic surgery such as total hip or knee replacement or hip fracture surgery. AHRQ also plans to look at what patient characteristics can predict or differentiate risk of VTE and bleeding, whether risk can be detected by venography or ultrasound, and how preventive treatments impact patient outcomes